Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.
- DOI
- 10.3389/fimmu.2022.939789
- Published
- 2022
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2022.939789,
title = {Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.},
author = {Chandra J and Hansen M and Labarriere N and Marigo I and Souza-Fonseca-Guimaraes F and Vujanovic L and Koguchi Y and Jacquelot N},
year = {2022},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2022.939789},
url = {https://doi.org/10.3389/fimmu.2022.939789}
}RIS
TY - JOUR TI - Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms. AU - Chandra J AU - Hansen M AU - Labarriere N AU - Marigo I AU - Souza-Fonseca-Guimaraes F AU - Vujanovic L AU - Koguchi Y AU - Jacquelot N PY - 2022 JO - Frontiers in immunology DO - 10.3389/fimmu.2022.939789 UR - https://doi.org/10.3389/fimmu.2022.939789 ER -
APA
J, C., M, H., N, L., I, M., F, S., L, V., Y, K., & N, J. (2022). Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2022.939789
Source records
- pubmed · retrieved 2026-09-26T05:21:03.088Z
- europe-pmc · retrieved 2026-09-26T05:21:03.099Z